Well, certainly not for my mum’s condition:

Campaigners have called for a fast-track assessment of a new breast cancer drug which may help save lives.

A global study found Femara (letrozole) was of most benefit to women at highest risk of the cancer returning, the New England Journal of Medicine reported.

BBC News Online

It’s fabulous news. Before mum’s secondary metastatic cancer was found, this tablet was apparently shrinking the evil lodger in her breast. She is still on this drug. Perhaps it may ease spread and growth in secondary mets?

To think that money dictates the spread of this drug to patients makes me ill. Money is the worst cancer of them all.